¹û¶³´«Ã½

ReNeuron widens clinical trials

The biotech minnow has received its first licensing payment from China's Fosun Pharma

M&C Saatchi warns on profits and accounting errors

The advertising agency is the latest listed entity to reveal accounting errors

Gooch & Housego bets on subsea rescue plan

The photonics specialist is looking to boost subsea revenues through increased capacity

XPS subject to margin pressure

The pension consultancy is a relatively small, nimble operator in a multi-billion pound industry – the commercial model is still evolving

Compass warns on European outlook

The contract caterer continues its M&A rationalisation

Suitor in search of a Consort

The drug delivery specialist is now in the cross-hairs of a Swedish industry peer

Smith & Nephew hit by Nawana departure

The market took fright at the departure of a chief executive for the second time in less than 18 months

Grafton guides for a profit shortfall

The building materials group delivered a profit warning which reflects a general slowdown in the construction and DIY markets.

In the midst of a lengthy correction

Easy assumptions on the housing market willfully ignore a less newsworthy, yet unavoidable determinant

Royal Dutch Shell's enhanced quarterly update

The oil and gas major is looking to increase transparency